Effect of the glucagon suppression ability in the sulfonylurea agents and other oral hypoglycemic agents.

Effect of the glucagon suppression ability in the sulfonylurea agents and other oral hypoglycemic agents. - Effect of the glucagon suppression ability in the sulfonylurea agents and other oral hypoglycemic agents.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007378

Enrollment

200

Registered

2012-02-28

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

sulfonylurea agents other hypoglycemic agents(except phenylalanine derivatives)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: diabetic patients The patient who does not have change in the cure for the past three months

Exclusion criteria

Exclusion criteria: The patient who has glucagonoma

Design outcomes

Primary

Measure	Time frame
glucagon,glucagon/FPG ratio,glucagon/CPR ratio	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026